Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralizati.
Methapharm Inc is a Brantford, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Advanz Pharma Corp. is a multinational pharmaceutical company headquartered in London.
All of Ankas programs share the same mission: to eliminate the impact of behavioral health problems for all people.